Indication

Staphylococcus aureus skin and skin structure infection

A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues. Read more about Staphylococcus aureus skin and skin structure infection

877 drugs 217 manufacturers

Drugs that treat it

Common Staphylococcus aureus skin and skin structure infection therapies.

Showing 82–90 of 877 drugs

Sort

PENICILLIN V POTASSIUM

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15

AUROBINDO PHARM

PENICILLIN V POTASSIUM

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15

TEVA USA

CEFPODOXIME PROXETIL

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+16

AUROBINDO PHARM

CLEOCIN HCL (clindamycin HCl)

SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19

PHARMACIA/UPJHN

CLINDAMYCIN PALMITATE HCL

SEPSIS CAUSED BY ANAEROBIC BACTERIA·+19

PADDOCK LABS.

PENICILLIN G PROCAINE

POST-EXPOSURE ANTHRAX PREVENTION·+29

Parke-Davis Pfizer

ZINACEF IN STERILE WATER (cefuroxime sodium/water for injection,sterile)

STREPTOCOCCAL SEPTICEMIA·+30

GSK

AVELOX (moxifloxacin HCl)

PLAGUE·+31

SCHERING CORP.

ZYVOX (linezolid)

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11

PHARMACIA/UPJHN

Filter & compare in the drug finder →Opens the drug finder with Staphylococcus aureus skin and skin structure infection preselected.

News & literature

Coming soon

Related codes

Coming soon

About Staphylococcus aureus skin and skin structure infection.

A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues.

It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response.

Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation.

Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia.

fda.gov
A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues
nih.gov
A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues
fda.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
nih.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
nih.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
nih.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation
cdc.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia
nih.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation
fda.gov
Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia

Personalize your experience

Follow Staphylococcus aureus skin and skin structure infection and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it